India’s Ministry of Health and Family Welfare (MoHFW) on 3 November 2026 proposed an amendment to Rule 43A of the Drugs Rules, 1945 to expand the authorised entry points through which drugs may be imported. The proposal includes additional Inland Container Depots (ICDs), a Special Economic Zone (SEZ) and an international airport. It is a draft regulatory change: the Ministry invited objections and suggestions, so the listed locations should not be described as already notified under a final amendment.
The development is useful for UPSC GS-II (governance and regulation), GS-III (industry, supply chains and health infrastructure), State PSC, pharmacy/health administration awareness and general current affairs. It also offers a compact way to understand the relationship between customs logistics and drug regulation.
What Rule 43A does
Rule 43A of the Drugs Rules, 1945 specifies authorised ports, airports, railway stations, road crossings and other entry points through which drugs may be imported into India. An authorised gateway is a designated location for regulated import processes; it is not an exemption from the substantive conditions that govern a product.
Drug imports remain subject to applicable requirements under the Drugs and Cosmetics Act, 1940 and Drugs Rules, 1945, including relevant import licences, registration, documentation, inspection and quality controls. Customs clearance and drug-regulatory compliance are related but distinct: a shipment’s arrival at an authorised customs location does not automatically establish that the product is legally marketable or that all regulatory conditions have been met.
Locations proposed in the 3 November draft
| Region / State | Proposed location | Type |
|---|---|---|
| Haryana | Sonipat, Piyala and Harsaru | Inland Container Depots |
| Uttar Pradesh | Dadri | Inland Container Depot |
| Gujarat | Gandhidham/Mundra | Inland Container Depot |
| Telangana | Sanath Nagar and Thimmapur, Hyderabad | Inland Container Depots |
| Karnataka | Whitefield, Bengaluru | Inland Container Depot |
| Karnataka | Bommasandra | Special Economic Zone |
| Uttar Pradesh | Noida International Airport | Airport for drug imports by air |
The PIB release also refers to existing notified import locations, including ICDs at Dhannad and Tihi in Indore, Madhya Pradesh, and airports already notified for drug imports. The proposal would add to—not replace—the existing network.
Primary source: MoHFW / PIB release, 3 November 2026 · Official Gazette portal
Why add inland depots and an airport?
International cargo does not always move directly from an overseas port to the final importer. Containerised shipments can be routed through inland logistics nodes where customs procedures, documentation, transport and warehousing are coordinated. An ICD is an inland facility that handles container cargo and customs-related processes, allowing trade flows to be managed away from a seaport.
Adding authorised gateways can improve geographic access for importers, reduce avoidable transport legs and distribute clearance activity across logistics centres. The Ministry’s stated objective is smoother import operations, logistics efficiency and a stronger supply chain for healthcare products. No quantified savings, new import volumes or guaranteed clearance-time reduction were given in the release; such outcomes should be treated as possible effects, not official performance claims.
Noida International Airport’s inclusion for drug imports by air is particularly relevant to time-sensitive shipments. Air cargo can be useful for high-value or urgent products, but airport authorisation does not itself establish cold-chain capacity, customs staffing or the readiness of every drug-regulatory inspection arrangement. Those operational details depend on the final rules and implementation.
Regulatory responsibilities: a three-part distinction
- Drug regulator: Central and state drug-control authorities administer the relevant licensing, registration, standards and inspection framework. The Central Drugs Standard Control Organisation (CDSCO) is India’s central drug-regulatory authority under the Directorate General of Health Services, MoHFW.
- Customs: Customs authorities handle the border/import process, declarations, classification, duties and clearance under customs law. A customs gateway and a drug-regulatory permission serve different functions.
- Importer and supply chain: Importers remain responsible for documents, licences, product conditions and compliant movement/storage. A location’s inclusion in Rule 43A does not remove the importer’s obligations.
These distinctions are important in exam questions that use “authorised port”, “import licence”, “registration” and “customs clearance” as if they were interchangeable. They are not.
Draft status: what candidates and businesses should check
The Ministry’s release says objections and suggestions may be sent to the Under Secretary (Drugs Regulation), MoHFW, U-6, Work Hall, C Wing, First Floor, Kartavya Bhawan-1, New Delhi–110001, or to the email address shown in the official release. The draft notification is accessible through the Gazette link provided by the Ministry. The consultation stage means stakeholders can examine the proposed wording and raise issues before finalisation.
For candidates, the safe sequence is: open the PIB release dated 3 November 2026; read the linked draft Gazette notification; identify the rule being amended and exact additional locations; check whether a later final notification has been issued before describing the proposal as law; and separate the gateway list from product-specific import permissions and quality requirements.
Background: Drugs Rules, 1945 and import regulation
The Drugs Rules, 1945 operate under the Drugs and Cosmetics Act, 1940, which provides the legal framework for regulating drugs and cosmetics in India. The framework covers matters such as import, manufacture, sale, distribution, standards and licensing. Over time, amendments and notifications update procedures, authorities, product categories and compliance requirements.
Rule 43A is a logistics-facing provision within this regulatory architecture: it deals with where imports may enter through specified gateways. Its importance is administrative and supply-chain related, while product safety is protected through the broader regulatory regime. The proposed addition of inland depots and a new airport should therefore be understood as a change to the authorised entry network, not a relaxation of drug standards.
Static GK and exam connections
- CDSCO: Central Drugs Standard Control Organisation; central drug-regulatory authority, MoHFW.
- ICD: Inland Container Depot; inland customs/logistics node for containerised cargo.
- SEZ: Special Economic Zone; a designated economic area under the SEZ framework, not automatically a separate country or customs-free zone for every legal purpose.
- Act and Rules: Drugs and Cosmetics Act, 1940; Drugs Rules, 1945.
- Draft vs final: a draft notification invites comments; final legal effect depends on the final notification and its commencement provisions.
- Locations: Sonipat, Piyala, Harsaru (Haryana); Dadri (Uttar Pradesh); Gandhidham/Mundra (Gujarat); Sanath Nagar/Thimmapur (Hyderabad); Whitefield and Bommasandra (Karnataka); Noida International Airport (Uttar Pradesh).
Possible MCQ areas
Questions may ask which rule is proposed to be amended, which ministry issued the proposal, what an ICD means, which airport is named, which state contains Bommasandra/Whitefield, or whether the proposal is already final. A mains answer can discuss regulatory facilitation without compromising quality assurance and explain why customs logistics and drug licensing are separate layers.
Related resources
Read Daily Current Affairs 3 November 2026, browse the Current Affairs Hub and use the Competitive Exams Preparation Hub for cross-exam revision.
Editorial caution: This article describes the proposal as published on 3 November 2026. Check the Official Gazette for any final notification or subsequent amendment.
